Nobilis Health Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported total revenue of $61,871,000 against $48,867,000 a year ago. Income from operations was $55,000 against $1,136,000 a year ago. Net income was $2,515,000 against $3,379,000 a year ago. Net income attributable to the company was $4,806,000 or $0.06 per basic and diluted share against net loss attributable to the company of $366,000 or $0.01 per basic and diluted share a year ago. EBITDA was $7,219,000 against $1,367,000 a year ago. Adjusted EBITDA was $8,510,000 against $6,933,000 a year ago. The increase in total revenue and total case volume in the second quarter compared to the same quarter the prior year was due primarily to the acquisitions of three hospitals in 2015.

For the six months, the company reported total revenue of $113,144,000 against $86,718,000 a year ago. Loss from operations was $9,639,000 against income from operations of $5,019,000 a year ago. Net loss was $4,249,000 against net income of $3,394,000 a year ago. Net loss attributable to the company was $159,000 or $0.00 per basic and diluted share against $4,848,000 or $0.08 per basic and diluted share a year ago. EBITDA was $3,603,000 against LBITDA of $1,810,000 a year ago. Adjusted EBITDA was $8,862,000 against $11,358,000 a year ago. The increase in total revenue and total case volume for the first six months of 2016 compared to the same period the prior year was due primarily to the acquisitions of three hospitals in 2015. Net cash provided by operating activities was $8.2 million compared to $5.2 million in the same period of 2015.

For the full year of 2016, the company is reiterating its original organic growth guidance of 20% for total revenues or $275 million, and 21% for adjusted EBITDA or $51 million.